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ABSTRACT: The association of type I diabetes mellitus with genes of the HLA class II system
has been well established. These genes may be different among populations due to the genetic
background predominating in each ethnic group. The objective of the present study was to
characterize HLA class II antigens in a Brazilian population of type I diabetics. The study was
conducted on 58 diabetic patients and 102 healthy controls of the same geographic area and of
similar ethnic background. B lymphocytes were separated from total lymphocytes by nylon wool.
HLA antigens were typed by a complement-dependent microlymphocytotoxicity method.  Data
were analyzed statistically by the two-tailed exact Fisher test. The frequencies of  HLA-DR3 and -
DR4 antigens, and of the combinations of HLA-DR3/DR4 antigens were significantly higher in
diabetics than in controls (P < 0.05). The frequencies of the HLA-DQ2 and DQ3 antigens did not
show significant differences when analyzed separately; however, the combinations of HLA-DR3
and HLA-DQ3, HLA-DR4 and HLA-DQ2 or HLA-DQ3, and HLA-DR3 HLA-DR4 and HLA-DQ3
antigens were significantly higher in the diabetic group than in the control (P < 0.05). Even though
HLA-DR2 and -DR7 antigens (associated with protection against the disease) were less frequent
than in the control group, no significant difference was detected after P correction.
UNITERMS: Histocompatibility Antigens. HLA Antigens. Diabetes Mellitus, Insulin-Dependent.
Pathogenesis.
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1. INTRODUCTION
Studies on different ethnic groups have strongly
suggested that susceptibility to type I diabetes (insu-
lin-dependent diabetes mellitus, IDDM) is associated
with certain histocompatibility antigens (HLA). HLA
class II molecules are implicated in the predisposition
to autoimmune disease such as IDDM since they
participate in the determination of the repertory of
antigenic peptides that T cells (T helper CD4+
lymphocytes) will be able to recognize.
Previous studies(1) have shown that the
HLA-DR3 and HLA-DR4 specificities of the class II
HLA complex increase the risk for IDDM, whereas
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HLA-DR2  is less frequent in these patients. These
associations of the HLA-DR locus with IDDM have
been detected in diabetic European and North Ameri-
can Caucasians and also in diabetic Black Americans
when compared to non-diabetic controls. However,
these associations were not detected in a diabetic Chi-
nese population. Brazilian studies(2) have also confirmed
the higher frequency of DR3 and DR4 among type I
diabetics when compared to healthy controls.
More recent studies(3/19) have shown that sus-
ceptibility to IDDM is associated more strongly  with
the alleles of the HLA-DQ locus. Certain molecules
expressed by the genes of the HLA-DQ locus can
present peptides derived from beta cells of pancreatic
islets which are recognized by T CD4 lymphocytes(17),
causing cell destruction in the organism itself. Specifi-
cally, these alleles of the HLA-DQ locus are
DQB1*0302 (former HLA-DQ3.2 allele or HLA-
DQ8 antigen) and DQA1*0301 alleles, usually linked
to the HLA-DR4 locus, forming the HLA-DRB1*04/
DQB1*0302 haplotype, and are frequent among
European and Northern Caucasian diabetics and
among Black diabetics. Among Japanese diabetics, the
most frequently observed association with DR4 is with
DQB1*0402 (HLA-DQ4 antigen). With respect to the
HLA-DR3 locus, a frequently detected association is
with DQB1*0201 and DQA1*0501 alleles among
North American and European Caucasians. In con-
trast, among Black diabetics, HLA-DR3 antigens
seems to be frequently associated with HLA-
DQB1*0201 (HLA-DQ2 antigen) and HLA-
DQB1*0402 (HLA-DQ4 antigen). Among Japanese
individuals, the association of IDDM with HLA-DR3
is infrequent, perhaps owing to the low frequency of
HLA-DR3 in this population. On the other hand, HLA-
DR9 is quite frequent among Japanese diabetics and
is usually associated with HLA-DQ1*0301 (HLA-
DQ7 antigen)( 8,13,15).
The objective of the present study is to charac-
terize HLA class II antigens of the DQ and DR loci in
a Brazilian population of type I diabetics from the
Southeastern region of the country.
2. MATERIAL AND METHODS
The study was conducted on 58 type I diabetics
(34 women and 24 men), all of them insulin-dependent,
predisposed to diabetic ketoacidosis, non-obese, ranging
in age from 8 to 60 years (mean, 24.5 ± 1.6 years).
The patients were from similar geographic regions,
especially the Northeastern region of the state of
São Paulo and the Southern region of Minas Gerais,
with an ethnic background consisting of a
miscegenation of European Caucasians, Brazilian
Indians and African Negroes. The control group
consisted of 102 healthy individuals (22 women and
80 men) from the same geographic area and with a
similar genetic background.
Total peripheral blood lymphocytes from these
patients were extracted by centrifugation at 1800 rpm
for 20 min and B lymphocytes were separated from
total lymphocytes by the nylon wool method (cotton
tip technique). HLA class II antigens were serologically
typed by the microlymphotoxicity method(20). The
following HLA class II antigens were typed: DR1, DR2,
DR3, DR4, DR5, DR6, DR7, DR8, DR9, DR11,  DR13,
DR14, DR52, DR53, DQ1, DQ2, DQ3 and DQ7.
Data were analyzed statistically by the two-tailed
exact Fisher test (21) and the P value obtained was
later corrected by multiplying by the number of
specificities tested (corrected P).
3. RESULTS
The frequency of HLA-DR and HLA-DQ
antigens in diabetic patients and controls is presented
in Table I, with significantly higher values detected
in diabetic patients for HLA-DR3 antigen (60.3%
for patients versus 18.6% for controls, P < 0.05),
HLA- DR4 antigen (53.4% for patients versus 27.4%
for controls, P < 0.05), and for the combination of HLA-
DR3/DR4  antigens (37.6% for patients versus 1.97%
for controls, P < 0.05). The HLA-DQ2 and HLA-
DQ3 antigens showed no significant differences when
analyzed separately. However, a significantly higher
frequency among diabetic patients was obtained for
the combinations of HLA-DR3 and HLA-DQ3
antigens (39.6% for patients versus 9.8% for controls,
P < 0.05), and for the combination of HLA-
DR3/DR4/DQ3 antigens (24.1% for patients versus
0.98% for controls, P < 0.05). The haplotype HLA-
DR4/DQ3 was found in 39.6% of  patients and in
18.6% of controls, P < 0.05. In contrast, the HLA-
DR2 and HLA-DR7 antigens were less frequently
observed in type I diabetics compared to controls
(13.8% versus 31.4%, and 5.2% versus 20.6%,
respectively), although no significant differences were
detected after the calculation of the corrected P.
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DQB1 genes). HLA-DQA1*0301 associated with the
DQB1*0302 allele, and HLA-DQA1*0501 associated
with DQB1*0101 are more frequently detected among
diabetics of the three ethnic groups (in the cis position
of the combination) compared to controls. In Blacks, a
significant association also occurs with DQA1*0301
and DQB1*0201 at the trans position. In Caucasians,
the genotypes most frequently involved in the suscep-
tibility to the disease are HLA-DR3/DQ2 antigens
(DQB1*0201/DQA1*0501 haplotype) and HLA-DR4/
DQ8 antigens (DQB1*0302/DQA1*0301 haplotype)
(8,13,15)
. In the Japanese population, patients with type I
diabetes are also associated with DQA1*0301/
DQB1*0303 and DQA1*0301/DQB1*0401 haplotypes,
both at the cis position. Blacks and Caucasians present
a weak association with DQA1*0301 and DQB1*0402
alleles. Among Asiatic Indian, Caribbean Black, Scan-
dinavian (7,18,19) and New Zealand diabetics (9,12) there
is also a high frequency of the combination of
DQB1*0302 alleles with the HLA-DR4 locus.
This association of the HLA-DQ locus with
IDDM seems to be due to the substitution of one amino
acid (aspartic acid) at position 57 in the beta chain of
the HLA- DQ molecule (HLA-DQ beta chain)  by
alanine, valine or serine but not aspartic acid (6). How-
ever, more recent studies have demonstrated that the
situation is much more complex, since Japanese dia-
betics (type I) frequently present DQ beta chains with
an aspartic acid residue (8,13).
À lower susceptibility to the development of
IDDM has been detected in individuals with various
combinations of DQA1 and DQB1 alleles at the cis
position, with a strong association of DQA1*0102 al-
lele with the HLA-DQB1*0602 allele (HLA-DQ6 an-
tigen) (13, 18,19) . These alleles related to a lower sus-
ceptibility to IDDM are frequently associated with the
HLA-DR2 locus.
In the present study there was a higher
frequency of HLA-DR3 and HLA-DR4 specificities
among diabetics, as also reported in a previous study
conducted on Brazilian patients(2) . The association of
the HLA-DR3 and HLA-DR4 antigens with the HLA-
DQ3 antigen was significantly more frequent among
diabetics, as also was the association of HLA-DR3 or
HLA-DR4 with the HLA-DQ2 antigen. With respect
to the alleles that “protect” against the disease, there
was a higher frequency of loci DR2 and DR7 in the
controls, although the difference was not significant
after P correction. HLA class II typings, as reported
here, were performed solely by serological methods,
using antibodies which reacted with broad HLA-DQ
4. DISCUSSION
Recent studies(11/19) have shown that suscepti-
bility to IDDM is strongly associated with combina-
tions of alleles at the HLA-DQ locus in Caucasian,
Black and Japanese subjects (HLA-DQA1 and HLA-
Table I - Frequency of HLA DR and DQ antigens
among 58 Brazilian type I diabetics and 102 healthy
control individuals
Antígenos HLA
Pacientes
(N = 58)
(%)
Controles
(N = 102)
(%)
DR1
DR2
DR3
DR4
DR5
DR6
DR7
DR8
DR9
DR11
DR13
DR14
DR52
DR53
DQ1
DQ2
DQ3
DQ7
DR3/DR4
DR3/DQW3
DR4/DQW3
DR4/DR3/DQW3
13 (22.4)
8 (13.8)**
35 (60.3)*
31 (53.4)*
5 (8.6)
1 (1.7)
3 (5.2)**
0 (0)
5 (8.6)
1 (1.7)
0 (0)
0 (0)
48 (82.7)
34 (58.6)
28 (48.3)
19 (32.7)
36 (62.0)
12 (20.7)
16 (27.6)*
23 (39.6)*
23 (39.6)*
14 (24.1)*
29 (28.4)
32 (31.4)
19 (18.6)
28 (27.4)
18 (17.2)
8 (7.8)
21 (20.6)
2 (1.9)
14 (13.7)
7 (6.8)
2 (1.9)
3 (2.9)
61 (59.8)
49 (48.0)
65 (63.7)
28 (27.4)
49 (49.0)
20 (19.6)
2 (1.97)
10 (9.8)
19 (18.6)
1 (0.98)
  * P < 0.05 compared to control (Fisher test);
** P < 0.05 compared to control only before correction (Fisher
test).
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conducted by us (22) or molecular studies of the HLA-
DRB1 locus conducted by the University of Campinas,
São Paulo, Brazil(23), indicate that immunogenetic
susceptibility to type I diabetes in Brazilians has a similar
immunogenetic profile, in terms of HLA class II alleles,
as has been reported for other Caucasian and
Caucasoid populations throughout the world(8,13,16/19).
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specificities such as HLA-DQ1 and HLA-DQ3
antigens. Certainly, the evaluation of HLA class II
specificities at the molecular levels will discriminate
particular associations with HLA-DQB1 alleles in the
Brazilian population. Although the Brazilian population
is highly miscegenated, preliminary molecular
evaluations of the HLA-DRB1 and DQB1 loci
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